Worldwide, regions struggle to lay the foundations for a functioning health care system. A lack of basic necessities, extreme poverty and insufficient infrastructure all limit access to quality, affordable health care. Some sobering statistics:
- Lack of necessities: 815 million people worldwide are affected by hunger. That is 11% of the world’s population.
- Extreme poverty prioritizes survival, not health care: 10% of the global population live on less than $2 per day.
- Infrastructure not keeping up: 40% of countries have less than one physician per 1,000 population.
- Increase in chronic and acute conditions across the globe: We have an increasingly aging, sick population in every region of the world.
Despite these obstacles, the world is undergoing rapid transformation. Economic conditions are improving, basic infrastructure is developing, and access to technology and the internet is unprecedented. With this advancement comes a new set of challenges and opportunities. Traditional emerging nation complications are increasingly well-controlled, and diseases that already plague developed nations such as diabetes and cancer are rising at alarming rates.
As non-communicable diseases anchor themselves in the developing world, it is increasingly apparent that disease is not one-size-fits-all. The genetic variation that will determine whether a medication actually works is staggering across regions and therapeutic areas.
At EY-Parthenon Life Sciences, we work with companies, investors, institutions and governments worldwide to bring innovative therapies, diagnostics, devices and services to patients and help them transform their health care systems in ways that are customized to their populations and the unique struggles they face. For more information on any of our example highlighted regions, please contact our EY-Parthenon life sciences leaders worldwide or our global team located across the US for questions and deployment.
- The World Health Organization Global Health Observatory (2017). Data retrieved via website.
- The 1000 Genomes Project Consortium et al., “A global reference for human genetic variation.” Nature, 2015, 526:68-74.
Want to learn more?
For more information, videos and accounts of our experiences building a world devoted to precision health, visit our Personalizing Precision Medicine page.
To further highlight the triumphs and challenges of precision medicine on a global scale, EY-Parthenon Global Head of Life Sciences Kristin Pothier and the Life Sciences team explore more topics through a LinkedIn blog series, The Business of Medicine.